PT357 – Dr. Hans Eriksson – Precision Psychiatry, Ketabon, and The Stress Response System

<p><span style="font-weight: 400;">In this episode, David interviews Dr. Hans Eriksson: clinical psychiatrist and Chief Medical Officer at HMNC Brain Health, which is currently in Phase 2 trials for Ketabon, a non-dissociative, prolonged-release oral capsule. </span></p> <p><span style= "font-weight: 400;">www.psychedelicstoday.com</span></p>